Clinical Lymphoma, Myeloma & Leukemia最新文献

筛选
英文 中文
Exploring Molecular Glues to Activate Proteasomes and Develop Shared and Personalized Neoantigen-Based Therapeutics in Multiple Myeloma 探索分子胶激活蛋白酶体和开发共享和个性化的基于新抗原的多发性骨髓瘤治疗方法
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03438-X
James Driscoll, James Ignatz-Hoover, Wei Huang, Derek Taylor
{"title":"Exploring Molecular Glues to Activate Proteasomes and Develop Shared and Personalized Neoantigen-Based Therapeutics in Multiple Myeloma","authors":"James Driscoll, James Ignatz-Hoover, Wei Huang, Derek Taylor","doi":"10.1016/S2152-2650(25)03438-X","DOIUrl":"10.1016/S2152-2650(25)03438-X","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Page S23"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145094607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iberdomide, Daratumumab, and Dexamethasone (IberDd) in Transplant-Ineligible/Deferred (TNE) Newly Diagnosed Multiple Myeloma (NDMM): Updated Results from the CC-220-MM-001 Trial 伊伯度胺、达拉单抗和地塞米松(IberDd)治疗新诊断的不符合移植条件/延迟移植(TNE)的多发性骨髓瘤(NDMM): CC-220-MM-001试验的最新结果
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03454-8
Anna Sureda Balarí, Abdullah Khan, Albert Oriol, Mercedes Gironella Mesa, Faiz Anwer, Cristina Encinas Rodríguez, Brea Lipe, Paula Rodríguez-Otero, Michael Amatangelo, Danny Jeyaraju, Kexin Jin, Thomas Solomon, Lilia Taningco, Olumoroti Aina, Paulo Maciag, Sagar Lonial
{"title":"Iberdomide, Daratumumab, and Dexamethasone (IberDd) in Transplant-Ineligible/Deferred (TNE) Newly Diagnosed Multiple Myeloma (NDMM): Updated Results from the CC-220-MM-001 Trial","authors":"Anna Sureda Balarí, Abdullah Khan, Albert Oriol, Mercedes Gironella Mesa, Faiz Anwer, Cristina Encinas Rodríguez, Brea Lipe, Paula Rodríguez-Otero, Michael Amatangelo, Danny Jeyaraju, Kexin Jin, Thomas Solomon, Lilia Taningco, Olumoroti Aina, Paulo Maciag, Sagar Lonial","doi":"10.1016/S2152-2650(25)03454-8","DOIUrl":"10.1016/S2152-2650(25)03454-8","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Pages S33-S34"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Anti-BCMA Antibody-Drug Conjugate HDP-101 with a Novel Amanitin Payload Shows Promising Data in Relapsed/Refractory Multiple Myeloma in a Phase 1/2a Clinical Trial as it Advances into Cohort 7 抗bcma抗体-药物偶联HDP-101与一种新的Amanitin有效载荷在复发/难治性多发性骨髓瘤的1/2a期临床试验中显示出有希望的数据,并进入队列7
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03463-9
Hajnalka Szaboki, Jonathan L. Kaufman, Shambavi Richard, Sebastian Grosicki, Istvan Takacs, Marc Raab, Cyrus Khandanpour, Andras Strassz, Andreas Pahl, Michael Kulke, Kristin Decker, Alexandra Braun, Thomas Philippi, Anette Last, Clemens Kruspel, Robert Orlowski, Frank Richard, Oliver Schonborn-Kellenberger, Throsten Lehr, Christiane Dings
{"title":"The Anti-BCMA Antibody-Drug Conjugate HDP-101 with a Novel Amanitin Payload Shows Promising Data in Relapsed/Refractory Multiple Myeloma in a Phase 1/2a Clinical Trial as it Advances into Cohort 7","authors":"Hajnalka Szaboki, Jonathan L. Kaufman, Shambavi Richard, Sebastian Grosicki, Istvan Takacs, Marc Raab, Cyrus Khandanpour, Andras Strassz, Andreas Pahl, Michael Kulke, Kristin Decker, Alexandra Braun, Thomas Philippi, Anette Last, Clemens Kruspel, Robert Orlowski, Frank Richard, Oliver Schonborn-Kellenberger, Throsten Lehr, Christiane Dings","doi":"10.1016/S2152-2650(25)03463-9","DOIUrl":"10.1016/S2152-2650(25)03463-9","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Page S40"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and Efficacy of Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma: A CIBMTR Study 西他tagene autoeucel治疗复发/难治性多发性骨髓瘤的安全性和有效性:一项CIBMTR研究
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03469-X
Doris Hansen, Danai Dima, Hira Mian, Ruta Brazauskas, Jakob Devos, Aimaz Afrough, Nausheen Ahmed, Larry Anderson, Aram Bidikian, Binod Dhakal, Yvonne Efebera, Muhammad Salman Faisal, Lohith Gowda, Hamza Hashmi, Abu-Sayeef Mirza, Meera Mohan, Ravi Narra, Taiga Nishihori, Marcelo C. Pasquini, Surbhi Sidana, Krina Patel
{"title":"Safety and Efficacy of Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma: A CIBMTR Study","authors":"Doris Hansen, Danai Dima, Hira Mian, Ruta Brazauskas, Jakob Devos, Aimaz Afrough, Nausheen Ahmed, Larry Anderson, Aram Bidikian, Binod Dhakal, Yvonne Efebera, Muhammad Salman Faisal, Lohith Gowda, Hamza Hashmi, Abu-Sayeef Mirza, Meera Mohan, Ravi Narra, Taiga Nishihori, Marcelo C. Pasquini, Surbhi Sidana, Krina Patel","doi":"10.1016/S2152-2650(25)03469-X","DOIUrl":"10.1016/S2152-2650(25)03469-X","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Pages S44-S45"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145094933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concurrent Administration of BCMA and GPRC5D Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Relapsed or Refractory Multiple Myeloma: Results from the Phase I TANDEMM Clinical Trial 同时给予BCMA和GPRC5D嵌合抗原受体(CAR) T细胞治疗复发或难治性多发性骨髓瘤:来自I期TANDEMM临床试验的结果
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03465-2
Sham Mailankody, Sneha Mitra, Kevin Herrera, Bachisio Ziccheddu, Briana Cadzin, Ozgur Can Eren, Tasmin Farzana, Tahmin Ullah, Jonathan Landa, Andriy Derkach, Jagrutiben Chaudhari, Devin Mcavoy, Kinga Hosszu, Gunjan Shah, Heather Landau, Francesco Maura, Ahmet Dogan, Sergio Giralt, Xiuyan Wang, Eric Smith, Karlo Perica
{"title":"Concurrent Administration of BCMA and GPRC5D Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Relapsed or Refractory Multiple Myeloma: Results from the Phase I TANDEMM Clinical Trial","authors":"Sham Mailankody, Sneha Mitra, Kevin Herrera, Bachisio Ziccheddu, Briana Cadzin, Ozgur Can Eren, Tasmin Farzana, Tahmin Ullah, Jonathan Landa, Andriy Derkach, Jagrutiben Chaudhari, Devin Mcavoy, Kinga Hosszu, Gunjan Shah, Heather Landau, Francesco Maura, Ahmet Dogan, Sergio Giralt, Xiuyan Wang, Eric Smith, Karlo Perica","doi":"10.1016/S2152-2650(25)03465-2","DOIUrl":"10.1016/S2152-2650(25)03465-2","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Pages S41-S42"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145095086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-Induction Outcomes and Updated Minimal Residual Disease Analysis from GMMG-HD10/DSMM-XX (MajesTEC-5): A Study of Teclistamab-Based Induction Regimens in Newly Diagnosed Multiple Myeloma (NDMM) GMMG-HD10/DSMM-XX (MajesTEC-5)诱导后结果和最新的最小残留疾病分析:新诊断的多发性骨髓瘤(NDMM)中基于替司他抗的诱导方案的研究
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03417-2
Marc Raab, Niels Weinhold, K. Martin Kortüm, Jan Krönke, Lilli Podola, Uta Bertsch, Julia Mersi, Stefanie Huhn, Michael Hundemer, Roland Fenk, Katja Weisel, Alexander Brobeil, Elias Mai, Natalie Schub, Florian Bassermann, Monika Engelhardt Florian Bassermann, Mathias Hänel, Hans Salwender, Raphael Teipel, Mohamed Amine Bayar, Leo Rasche
{"title":"Post-Induction Outcomes and Updated Minimal Residual Disease Analysis from GMMG-HD10/DSMM-XX (MajesTEC-5): A Study of Teclistamab-Based Induction Regimens in Newly Diagnosed Multiple Myeloma (NDMM)","authors":"Marc Raab, Niels Weinhold, K. Martin Kortüm, Jan Krönke, Lilli Podola, Uta Bertsch, Julia Mersi, Stefanie Huhn, Michael Hundemer, Roland Fenk, Katja Weisel, Alexander Brobeil, Elias Mai, Natalie Schub, Florian Bassermann, Monika Engelhardt Florian Bassermann, Mathias Hänel, Hans Salwender, Raphael Teipel, Mohamed Amine Bayar, Leo Rasche","doi":"10.1016/S2152-2650(25)03417-2","DOIUrl":"10.1016/S2152-2650(25)03417-2","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Pages S9-S10"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145095213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Validation of Revised Diagnostic Criteria for Light Chain MGUS and Risk of Progression to Malignancy 修订的轻链MGUS诊断标准和恶性进展风险的临床验证
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03445-7
Lærke Andersen, Cecilie Maeng, Sæmundur Rögnvaldsson, Thorir Long, Christian Brieghel, Emil Hermansen, Morten Andersen, Carsten Niemann, Sigurdur Kristinsson, Sigrun Thorsteinsdottir
{"title":"Clinical Validation of Revised Diagnostic Criteria for Light Chain MGUS and Risk of Progression to Malignancy","authors":"Lærke Andersen, Cecilie Maeng, Sæmundur Rögnvaldsson, Thorir Long, Christian Brieghel, Emil Hermansen, Morten Andersen, Carsten Niemann, Sigurdur Kristinsson, Sigrun Thorsteinsdottir","doi":"10.1016/S2152-2650(25)03445-7","DOIUrl":"10.1016/S2152-2650(25)03445-7","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Pages S27-S28"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145094208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-World Bispecific Antibody Therapy for Multiple Myeloma: Insights from Dutch Nationwide Registry 真实世界双特异性抗体治疗多发性骨髓瘤:来自荷兰全国注册的见解
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03471-8
Marjolein Appelman, Rimke Oostvogels, Annemiek Broijl, Laurens Franssen, Paul Geerts, Ellen van der Spek, Heleen de Lil, Cleo van Rooijen, Paula Ypma, Monique Minnema, Wilfried Roeloffzen, Catharina van Elsen, Elizabeth de Kort, Kaz Groen, Inger Nijhof, Ruth Wester
{"title":"Real-World Bispecific Antibody Therapy for Multiple Myeloma: Insights from Dutch Nationwide Registry","authors":"Marjolein Appelman, Rimke Oostvogels, Annemiek Broijl, Laurens Franssen, Paul Geerts, Ellen van der Spek, Heleen de Lil, Cleo van Rooijen, Paula Ypma, Monique Minnema, Wilfried Roeloffzen, Catharina van Elsen, Elizabeth de Kort, Kaz Groen, Inger Nijhof, Ruth Wester","doi":"10.1016/S2152-2650(25)03471-8","DOIUrl":"10.1016/S2152-2650(25)03471-8","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Pages S45-S46"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145094760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of Anti-AL Amyloidosis CAR Phagocyte Therapy 抗al淀粉样变CAR吞噬细胞疗法的研究进展
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03495-0
Jing Fu, Huihui Ma, Shirong Li, Michael Hughes, Gavreel Kalantarov, Guifen Liu, Suzanne Lentzsch, Markus Mapara
{"title":"Development of Anti-AL Amyloidosis CAR Phagocyte Therapy","authors":"Jing Fu, Huihui Ma, Shirong Li, Michael Hughes, Gavreel Kalantarov, Guifen Liu, Suzanne Lentzsch, Markus Mapara","doi":"10.1016/S2152-2650(25)03495-0","DOIUrl":"10.1016/S2152-2650(25)03495-0","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Pages S60-S61"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145095089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Value of Progression-Free Survival (PFS) from the Perspectives of Patients with Multiple Myeloma (MM) and Treating Physicians: Quantitative Research Findings from Eight Countries 从多发性骨髓瘤(MM)患者和治疗医生的角度来看,无进展生存期(PFS)的价值:来自八个国家的定量研究结果
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2025-09-01 DOI: 10.1016/S2152-2650(25)03422-6
Aaron Rosenberg, Thomas Chalopin, Kushal Modi, Alison Bulkley, Kyla Finlayson, Corey Neff, Oliver Will, Yu-Hsuan Shih, Laurie Eliason, Thomas Marshall, Zander Pittman, Marc DeCongelio
{"title":"The Value of Progression-Free Survival (PFS) from the Perspectives of Patients with Multiple Myeloma (MM) and Treating Physicians: Quantitative Research Findings from Eight Countries","authors":"Aaron Rosenberg, Thomas Chalopin, Kushal Modi, Alison Bulkley, Kyla Finlayson, Corey Neff, Oliver Will, Yu-Hsuan Shih, Laurie Eliason, Thomas Marshall, Zander Pittman, Marc DeCongelio","doi":"10.1016/S2152-2650(25)03422-6","DOIUrl":"10.1016/S2152-2650(25)03422-6","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Pages S12-S13"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145095171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信